Asparagus Fructans as Emerging Prebiotics.
Level 5 - mechanism / opinion, no new human data
In vitro bench research and physicochemical characterization with no human clinical data.
PubMed 36613297 · doi:10.3390/foods12010081
What was done
Researchers extracted fructans from asparagus root by-products and compared their chemical composition, physicochemical characteristics, and in vitro biological activities against three commercial fructans derived from chicory (including Orafti ® GR) and agave. Analyses included Fourier-transform infrared spectroscopy (FTIR), measurement of degree of polymerization (DP), viscosity, antioxidant capacity, in vitro prebiotic activity, and preliminary assays related to infertility and diabetes.
What was found
Asparagus fructans demonstrated total fructan, simple sugar, and moisture levels similar to commercial sources, but had higher contents of ash, protein, and phenolic compounds. Degree of polymerization reached up to 25 for asparagus fructans, falling between Orafti ® GR (up to 40) and the other commercial products (DP 10–11). Asparagus fructans displayed higher viscosity and antioxidant activity compared to Orafti ® GR, and all four sources showed similar in vitro prebiotic activity. Specific numerical metrics for chemical assays and preliminary disease models were not reported in the abstract.
Why it matters
Asparagus roots represent a viable agricultural waste stream that could serve as an alternative commercial source of prebiotic fructans with added antioxidant properties.
Limits
The study is entirely in vitro and preclinical, lacking in vivo animal models or human clinical trials. The abstract provides no quantitative measurements, error ranges, or specific methodologies for the reported preliminary health effect assays.
Cited by
- supports Asparagus and artichokes are rich sources of inulin.